NDC 42192-619 – Naproxen
Naproxen 125 mg/5mL · Suspension · Oral
Product NDC42192-619
Product details
- Brand name
- Naproxen
- Generic name
- Naproxen
- Labeler
- Acella Pharmaceuticals, LLC
- Dosage form
- Suspension
- Route
- Oral
- Marketing category
- NDA AUTHORIZED GENERIC · NDA018965
- Marketed since
- November 12, 2020
- Marketing end
- January 31, 2028
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
Active ingredients
- Naproxen 125 mg/5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 42192-619-16 | 473 mL in 1 BOTTLE (42192-619-16) | Nov 12, 2020 |
Recalls mentioning this NDC
- D-0523-2026 May 13, 2026 · Class II
Chemical contamination; presence of lead and lithium above specification
Other Naproxen products
- 69238-1730 Naproxen 25 mg/mL · Suspension · Amneal Pharmaceuticals NY LLC
- 59651-528 Naproxen 125 mg/5mL · Suspension · Aurobindo Pharma Limited
- 31722-682 Naproxen 25 mg/mL · Suspension · Camber Pharmaceuticals, Inc.
- 0054-3630 Naproxen 125 mg/5mL · Suspension · Hikma Pharmaceuticals USA Inc.
- 50090-4636 Naproxen 375 mg/1 · Tablet · A-S Medication Solutions
- 50090-4638 Naproxen 375 mg/1 · Tablet · A-S Medication Solutions
- 50090-1585 Naproxen 375 mg/1 · Tablet · A-S Medication Solutions
- 50090-0483 Naproxen 500 mg/1 · Tablet · A-S Medication Solutions
- 50090-0482 Naproxen 500 mg/1 · Tablet · A-S Medication Solutions
- 50090-0481 Naproxen 500 mg/1 · Tablet · A-S Medication Solutions
- 50090-1583 Naproxen 375 mg/1 · Tablet · A-S Medication Solutions
- 50090-1584 Naproxen 375 mg/1 · Tablet · A-S Medication Solutions